Parallax Volatility Advisers, L.P. Iveric Bio, Inc. Transaction History

Parallax Volatility Advisers, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$18.67 - $24.56 $896 - $1,178	48 New	48 $1,000
Q3 2022 Nov 14, 2022	SELL	$9.4 - $18.59 $893,752 - $1.77 Million	-95,080 Reduced 93.17%	6,973 $125,000
Q2 2022 Aug 15, 2022	BUY	$9.12 - $18.9 $694,269 - $1.44 Million	76,126 Added 293.62%	102,053 $982,000
Q3 2021 Nov 15, 2021	BUY	$7.07 - $17.5 $183,303 - $453,722	25,927 New	25,927 $421,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.